20 likes | 41 Views
The acquisition of CBD Capital enables GenCanna to broaden its bulk CBD product offering and distribution capabilities to its overseas customers, as well as expand its formulation capabilities and business-to-business operations through CBD Capitalu2019s network of valued partners. CBD Capital also brings with it several sub-brands that will now enjoy accelerated productu00a0 development and market expansion as more resources are devoted to them. The addition of CBD Capital follows GenCannau2019s acquisition of London-based CBD finished goods formulator and brand accelerator,
E N D
1 (877) 340-6070 – sales@GenCanna.com +44 1483 930401 – Europe@GenCanna.com Bulk Ingredients Finished Goods Bottling Compliance Blog Careers Contact Us American CBD Pioneer GenCanna Acquires London-Based CBD Provider, CBD Capital Have Questions or Ready to Buy? Acquisition signi?cantly increases GenCanna’s expanding bulk ingredient and ?nished goods operations Contact our sales team using the form below or call 1 (877) 340-6070. in the United Kingdom and key European and global markets First Name * WINCHESTER, KENTUCKY — September 1, 2021— GenCanna (gencannastage.wpengine.com), an industry founding producer of premium full-spectrum and broad-spectrum CBD and other quality cannabinoids for Last Name * bulk supply and ?nished goods formulation, announced today that it has acquired CBD Capital Ltd (cbd- capital.com), the leading provider of CBD distillate, isolate, and water-soluble bulk ingredients as well as Email * white and private label services to the United Kingdom, the European Union and markets worldwide. CBD Capital CEO, Hassan Akhtar, will continue to serve in his current role. Phone The acquisition of CBD Capital enables GenCanna to broaden its bulk CBD product o?ering and distribution capabilities to its overseas customers, as well as expand its formulation capabilities and business-to- Company * business operations through CBD Capital’s network of valued partners. CBD Capital also brings with it several sub-brands that will now enjoy accelerated product development and market expansion as more Title * resources are devoted to them. The addition of CBD Capital follows GenCanna’s acquisition of London- based CBD ?nished goods formulator and brand accelerator, Taylor Mammon, further anchoring Send GenCanna’s footprint across the global CBD market. “The highly strategic acquisition of CBD Capital widens and solidi?es GenCanna’s leadership position across high-growth CBD markets in the United Kingdom, the European Union, and the rest of the world,” said Search... Andrew Barnett, CEO of GenCanna. “As a long-term partner of CBD Capital, we are deeply familiar with its impressive business, which will signi?cantly boost GenCanna’s ability to provide our growing global customer base with deepened and broadened services — such as greater formulation capability and Recent Posts expanded ?nished goods versatility, increased supply chain ?exibility, and quick-to-market turnaround. We CBD Bioavailability: Challenges look forward to leveraging CBD Capital’s strong industry experience and passion as we develop end-to-end, and Improvements turnkey solutions that speed sales and maximize gross margin dollars for our customers. This is the GenCanna way.” Endocannabinoid System 101: What CBD Brands Should Know With CBD Capital’s recent opening of a new base in Rotterdam, Netherlands, which facilitates next-day distribution capabilities to markets throughout the European Union, the company is strategically and Top Four Reasons to Test Your logistically positioned to further growth and market penetration. Ingredients and Finished Goods – “We are thrilled to join the growing family of GenCanna CBD companies,” said CBD Capital CEO, Hassan And Have A COA on File. Akhtar. “The injection of both ?nancial and human capital, combined with GenCanna’s formidable CBD American CBD Pioneer GenCanna ingredient extraction and re?nement sciences, and its sterling compliance track record, will now greatly Acquires London-Based CBD facilitate the expansion and completion of several key channel strategies and market growth initiatives Provider, CBD Capital currently within the CBD Capital pipeline.” Drops, Capsules, Gummies or About CBD Capital Ltd. Edibles? CBD Form Factors to CBD Capital Ltd. (cbd-capital.com) is a global CBD supplier, distributing internationally accredited, pharmaceutical-grade, wholesale phytocannabinoids to leaders in the global cannabidiol industry. Validated through regulatory accreditations and certi?cations from Include in Your Product Line. multiple governments across the United Kingdom, the European Union, and throughout the world, the company’s state-of-the-art extraction techniques combine with a diverse international supply chain to ensure the provision of industry-competitive, pharmaceutical-grade CBD bulk and ?nished goods. Categories UK Contact: Hassan Akhtar Article CEO, CBD Capital +44 (0) 1483 930 401 Press hassan@cbd-capital.com About Taylor Mammon Taylor Mammon Ltd. (taylormammon.com) is a white label manufacturer and brand distributor of CBD-infused goods. Taylor Mammon Archives sees the bene?ts in the power of CBD and has created a business model that a?ords its brand partners total ownership over their
brands, while enabling end-consumers to bene?t from the exciting applications of CBD. Taylor Mammon continually innovates new December 2022 products to meet its partners’ rigorous demands. November 2022 UK Contact: Nathan Wogman Managing Director, Taylor Mammon October 2022 0208.344.2005 nathan@taylormammon.com September 2021 About GenCanna August 2021 GenCanna (gencannastage.wpengine.com) is a vertically integrated pioneer-producer of premium hemp-derived CBD and other cannabinoids in both bulk supply as well as in high-quality ?nished goods formulations. GenCanna’s optimized supply chain is built and operated under the strictest quality assurance standards and regulatory mandates (BRCGS, cGMP), and the company continues to July 2021 achieve the industry’s most sought-after compliance validations, including the UK’s FSA’s Novel Foods Application. Learn more at gencannastage.wpengine.com/compliance. June 2021 US Contact: Andrew G. Barnett May 2021 CEO, GenCanna 203.972.1718 March 2021 andrew.barnett@gencanna.com ©2021 GenCanna, Winchester, KY February 2021 September 1, 2021 Share This Story, Choose Your Platform! Bottling Private Label 435 East Washington Street Bulk Ingredients Blog Winchester, KY 40391 Finished Goods Careers 1 (877) 340-6070 Catalogs & Spec Sheets Contact Us sales@GenCanna.com Compliance Legal © Copyright 2023 GenCanna. All Rights Reserved. Sitemap